How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?

Title : How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?

Source : PubMed
ID : 26743093
Authors : Saeed, Sahar; Strumpf, Erin C.; Walmsley, Sharon L.; Rollet-Kurhajec, Kathleen; Pick, Neora; Martel-Laferriere, Valerie; Hull, Mark; Gill, M. John; Cox, Joseph; Cooper, Curtis; Klein, Marina B.; Cohen, Jeff; Conway, Brian; Cooper, Curtis; Cote, Pierre; Cox, Joseph; Gill, John; Haider, Shariq; Harris, Marianne; Haase, David; Hull, Mark; Montaner, Julio; Moodie, Erica; Pick, Neora; Rachlis, Anita; Rouleau, Danielle; Sandre, Roger; Tyndall, Joseph Mark; Vachon, Marie-Louise; Walmsley, Sharon; Wong, David
Year : 2016
Disease Category : HIV/AIDS
Focused Population : Not Specified
Priori/Posteriori : Priori
Single-study Generalibility? : Multiple
Score/Non-Score : Non-score
Tutorial/Method : NHANES_T2D
Compared general demographic and patient characteristics : Yes
Compared disease-specific clinical characteristics : Yes
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : No
Eligible patients (by applying criteria) vs. ineliglble patients (by applying criteria) : Yes
Eligible patients vs. general population : Yes
Real-world data sources : Canadian Coinfection Cohort
Target Population Data Type Levels : National